Gadolinium Market Size To Reach $380.5 Million By 2033

Gadolinium Market Growth & Trends

The global gadolinium market size is anticipated to reach USD 380.5 million by 2033 and is projected to grow at a CAGR of 4.0% from 2026 to 2033, according to a new report by Grand View Research, Inc. The growing adoption of magnetic resonance imaging is a major driver of the gadolinium industry, as gadolinium-based contrast agents are widely used to improve the visualization of tissues, organs, and blood vessels during MRI examinations. Rising demand for non-invasive diagnostic procedures, increasing prevalence of cancer and neurological disorders, and expansion of diagnostic imaging infrastructure are supporting the use of contrast-enhanced MRI. Recent clinical data also indicate continued growth in gadolinium contrast utilization, with brain MRI as a major application.

Increasing healthcare expenditure and the expansion of advanced diagnostic infrastructure in emerging economies are further supporting market growth. Countries across the Asia-Pacific, particularly China and India, are investing in hospitals, diagnostic centers, and medical imaging equipment, thereby increasing access to MRI examinations. The expansion of demand for MRI contrast media in India, for example, reflects the broader development of diagnostic imaging capabilities and healthcare infrastructure in the region.

Technological advancements in gadolinium-based contrast agents are creating additional growth opportunities. Pharmaceutical companies are developing macrocyclic formulations and lower-dose contrast agents that aim to maintain diagnostic performance while reducing gadolinium exposure. In June 2026, the FDA approved Bayer’s AMBELVIST, a low-dose macrocyclic gadolinium-based contrast agent, demonstrating continued innovation in the field and supporting demand for higher-purity gadolinium materials used in advanced medical applications.

Growing demand from nuclear power generation is another important driver for the gadolinium industry. Gadolinium has high neutron-absorption capability, making it useful in nuclear reactor control and safety applications. As countries pursue nuclear energy to strengthen electricity supply, energy security, and low-carbon generation, demand for neutron-absorbing materials is expected to support the consumption of gadolinium compounds and alloys. Gadolinium is also used in specialized alloys, magnetic materials, electronics, phosphors, and optical applications, providing diversification beyond the healthcare sector.

The expansion of advanced magnetic and electronic technologies is expected to further stimulate demand for gadolinium over the forecast period. Gadolinium can improve the thermal stability and magnetic performance of specialized alloys and NdFeB-based magnets, supporting applications in electric vehicle motors, wind turbines, and other high-performance equipment. Its use in phosphors, scintillation detectors, electronic devices, and magnetic refrigeration also creates opportunities as demand for energy-efficient technologies and advanced electronics increases. This diversification reduces the market’s dependence on medical imaging and creates additional long-term demand across industrial and technology applications. 

 Request a free sample copy or view report summary: Gadolinium Market Report

Gadolinium Market Report Highlights

• Based on end use, the medical imaging / MRI contrast agents segment led the market with the largest revenue share of 42.0% in 2025, driven by the increasing adoption of MRI procedures for the diagnosis and monitoring of neurological disorders, cancer, cardiovascular diseases, and other complex medical conditions, along with the widespread use of gadolinium based contrast agents to improve image quality and enhance the detection and characterization of lesions.

• Asia Pacific dominated the market with the largest revenue share of 52.9% in 2025, supported by expanding healthcare infrastructure, rising MRI installations, increasing prevalence of chronic diseases, and growing demand for advanced diagnostic imaging across China, Japan, and India. Government investments in healthcare modernization and improved access to imaging services are further increasing the adoption of MRI contrast agents in the region. 

Gadolinium Market Segmentation

Grand View Research has segmented the global gadolinium market based on the end use and region:

Gadolinium End Use Outlook (Revenue, USD Million, 2021 - 2033)

• Medical Imaging / MRI Contrast Agents

• Magnetic Refrigeration & Special Alloys

• Nuclear Reactors

• Phosphors & Optical Glass

Gadolinium Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • France

  • Italy

  • UK

• Asia Pacific

  • China

  • India

  • South Korea

  • Japan

• Latin America

  • Brazil

• Middle East & Africa

List of Key Companies in the Gadolinium Market Include

• Alpha Chemika

• American Elements

• IREL (India) Limited

• Lynas Rare Earths Limited

• Merck KGaA

• Nippon Yttrium Co., Ltd.

• Shin Etsu Chemical Co., Ltd.

• Solvay S.A.

• Star Earth Minerals Pvt. Ltd.

• Thermo Fisher Scientific